Having trouble viewing this email? View in your browser.
 
Weekly News
27 July 2021

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 
ESCMID Research Grants 2022: apply now!

The application period for ESCMID Research Grants 2022 is open and the deadline for submitting your applications is 10 September 2021. For this call, only projects dealing with Bacterial Infections & Diseases (incl. diagnostics, pathogenesis, antibacterial susceptibility & resistance, antibacterial stewardship, vaccines) will be accepted. For further information click here and please also see the Research Grants FAQ.

 
› Read more
 
ESCMID Executive Committee Elections 2021: Get your nominations in!

At the end of 2021, elections will be held among the membership to fill three (out of eight) positions in the ESCMID Executive Committee, one representing clinical microbiology and two infectious diseases.

ESCMID would like to encourage you to propose candidates by 31 August 2021 on the ESCMID website.

Participate now in the SurvEthics, from the Ethics Advisory Committee

The Ethics Advisory Committee has launched an anonymous survey to better understand ESCMID members and survey participants' involvement in bioethics and their perceptions of priorities and gaps in the field of bioethics and Infectious Diseases. The results will help the EEAC to better define ethical issues and design a strategy to approach them in a consistent and systematic way. Complete the survey here.

EMA communication: Use of antibiotics in animals is decreasing

EMA would like inform you of the latest report published by the European Food Safety Authority (EFSA), the European Medicines Agency and the European Centre for Disease Prevention and Control (ECDC), which says that the use of antibiotics has decreased and is now lower in food-producing animals than in humans.

For more related content, please click here

Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables: development and validation of the PRIORITY model

This study aimed to develop and validate a prediction model, based on clinical history and examination findings on initial diagnosis of COVID-19, to identify patients at risk of critical outcomes. The PRIORITY model, based on easily-obtained clinical information, had good discrimination and generalizability for identifying COVID 19 patients at risk of critical outcomes.
Read the full article here